Literature DB >> 15525770

Deletion of N-type calcium channels alters ethanol reward and reduces ethanol consumption in mice.

Philip M Newton1, Christine J Orr, Melisa J Wallace, Chanki Kim, Hee-Sup Shin, Robert O Messing.   

Abstract

N-type calcium channels are modulated by acute and chronic ethanol exposure in vitro at concentrations known to affect humans, but it is not known whether N-type channels are important for behavioral responses to ethanol in vivo. Here, we show that in mice lacking functional N-type calcium channels, voluntary ethanol consumption is reduced and place preference is developed only at a low dose of ethanol. The hypnotic effects of ethanol are also substantially diminished, whereas ethanol-induced ataxia is mildly increased. These results demonstrate that N-type calcium channels modulate acute responses to ethanol and are important mediators of ethanol reward and preference.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15525770      PMCID: PMC6730245          DOI: 10.1523/JNEUROSCI.3446-04.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  16 in total

Review 1.  Genes and Alcohol Consumption: Studies with Mutant Mice.

Authors:  J Mayfield; M A Arends; R A Harris; Y A Blednov
Journal:  Int Rev Neurobiol       Date:  2016       Impact factor: 3.230

2.  P/Q-type voltage-gated calcium channels mediate the ethanol and CRF sensitivity of central amygdala GABAergic synapses.

Authors:  F P Varodayan; M L Logrip; M Roberto
Journal:  Neuropharmacology       Date:  2017-07-19       Impact factor: 5.250

3.  Increased response to morphine in mice lacking protein kinase C epsilon.

Authors:  P M Newton; J A Kim; A J McGeehan; J P Paredes; K Chu; M J Wallace; A J Roberts; C W Hodge; R O Messing
Journal:  Genes Brain Behav       Date:  2006-08-07       Impact factor: 3.449

Review 4.  Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation.

Authors:  Giovanni Addolorato; Lorenzo Leggio; F Woodward Hopf; Marco Diana; Antonello Bonci
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

5.  Developmentally regulated actions of alcohol on hippocampal glutamatergic transmission.

Authors:  Manuel Mameli; Paula A Zamudio; Mario Carta; C Fernando Valenzuela
Journal:  J Neurosci       Date:  2005-08-31       Impact factor: 6.167

6.  The α5 neuronal nicotinic acetylcholine receptor subunit plays an important role in the sedative effects of ethanol but does not modulate consumption in mice.

Authors:  Nathan Santos; Susmita Chatterjee; Andrea Henry; Joan Holgate; Selena E Bartlett
Journal:  Alcohol Clin Exp Res       Date:  2012-11-16       Impact factor: 3.455

7.  Protein Kinase C Epsilon Activity in the Nucleus Accumbens and Central Nucleus of the Amygdala Mediates Binge Alcohol Consumption.

Authors:  Debra K Cozzoli; Justin Courson; Charlotte Rostock; Rianne R Campbell; Melissa G Wroten; Hadley McGregor; Amanda L Caruana; Bailey W Miller; Jia-Hua Hu; Ping Wu Zhang; Bo Xiao; Paul F Worley; John C Crabbe; Deborah A Finn; Karen K Szumlinski
Journal:  Biol Psychiatry       Date:  2015-03-05       Impact factor: 13.382

8.  A blocker of N- and T-type voltage-gated calcium channels attenuates ethanol-induced intoxication, place preference, self-administration, and reinstatement.

Authors:  Philip M Newton; Lily Zeng; Victoria Wang; Jacklyn Connolly; Melisa J Wallace; Chanki Kim; Hee-Sup Shin; Francesco Belardetti; Terrance P Snutch; Robert O Messing
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

Review 9.  Alcoholism and alternative splicing of candidate genes.

Authors:  Toshikazu Sasabe; Shoichi Ishiura
Journal:  Int J Environ Res Public Health       Date:  2010-03-30       Impact factor: 3.390

10.  Nonmuscle myosin IIB as a therapeutic target for the prevention of relapse to methamphetamine use.

Authors:  E J Young; A M Blouin; S B Briggs; S E Sillivan; L Lin; M D Cameron; G Rumbaugh; C A Miller
Journal:  Mol Psychiatry       Date:  2015-08-04       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.